Peptron

087010.KQ

224.57 USD

9.10

+4.22%

Overview

Last close

224.57 usd

Market cap

3.44B usd

52 week high

255.17 usd

52 week low

16.05 usd

Target price

25.11 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1345.2938

Price/Book Value

48.3903

Enterprise Value

4.92B usd

EV/Revenue

1324.7647

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.17M usd

Gross Profit TTM

3.20M usd

EBITDA TTM

-7.70M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

119.66M usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.